Background In hemodialysis patients, adynamic bone disease has been reported to be closely associated with low levels of parathyroid hormone (PTH) 
Introduction
Hypoparathyroidism is closely associated with low bone turnover osteodystrophy, mainly adynamic bone disease (ABD), which has been recognized as a risk factor for bone fracture, vascular calcification, and calciphylaxis in hemodialysis patients (1) . ABD is reported to be detected in onefourth of bone biopsy specimens in dialysis patients (2, 3) . Akizawa et al revealed that Japanese dialysis patients with serum levels of intact parathyroid hormone (iPTH) below 60 pg/mL had a high incidence of ABD in bone biopsy specimens (4 (5, 6) .
Sevelamer hydrochloride is a new phosphate binder that does not contain either calcium or aluminum and is already being used world wide (7) (8) (9) . The switch from CaCO3 to sevelamer hydrochloride was reported to decrease not only the serum phosphate concentration but also serum calcium levels, resulting in increased levels of PTH in hemodialysis patients (10) . These 
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Results
The results were analyzed in 31 patients (11 
Serum levels of calcium decreased by treatment of sevelamer hydrochloride
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Discussion
Sevelamer hydrochloride reduced the serum calcium concentration, which increased PTH levels, resulting in the improvement of markers of bone remodeling activity. These therapeutic effects were shown even in patients with DM, who are characterized by low bone turnover resulting from impaired secretion of PTH (5, 6) .
Adynamic bone disease has been reported in one-fourth of bone biopsy specimens from dialysis patients (2, 3 (14) . However, the use of low calcium dialysate has been reported to result in an increase in PTH in diabetic patients (15) 
